001     124440
005     20240228145514.0
024 7 _ |a 10.1016/j.ccell.2017.05.006
|2 doi
024 7 _ |a pmid:28609656
|2 pmid
024 7 _ |a 1535-6108
|2 ISSN
024 7 _ |a 1878-3686
|2 ISSN
024 7 _ |a altmetric:21026032
|2 altmetric
037 _ _ |a DKFZ-2017-01317
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Yuan, Detian
|0 P:(DE-He78)b7267d2eb18316483adbd62e60d9a3ad
|b 0
|e First author
245 _ _ |a Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS.
260 _ _ |a Cambridge, Mass.
|c 2017
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1533732513_31083
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Intrahepatic cholangiocarcinoma (ICC) is a highly malignant, heterogeneous cancer with poor treatment options. We found that mitochondrial dysfunction and oxidative stress trigger a niche favoring cholangiocellular overgrowth and tumorigenesis. Liver damage, reactive oxygen species (ROS) and paracrine tumor necrosis factor (Tnf) from Kupffer cells caused JNK-mediated cholangiocellular proliferation and oncogenic transformation. Anti-oxidant treatment, Kupffer cell depletion, Tnfr1 deletion, or JNK inhibition reduced cholangiocellular pre-neoplastic lesions. Liver-specific JNK1/2 deletion led to tumor reduction and enhanced survival in Akt/Notch- or p53/Kras-induced ICC models. In human ICC, high Tnf expression near ICC lesions, cholangiocellular JNK-phosphorylation, and ROS accumulation in surrounding hepatocytes are present. Thus, Kupffer cell-derived Tnf favors cholangiocellular proliferation/differentiation and carcinogenesis. Targeting the ROS/Tnf/JNK axis may provide opportunities for ICC therapy.
536 _ _ |a 316 - Infections and cancer (POF3-316)
|0 G:(DE-HGF)POF3-316
|c POF3-316
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Huang, Shan
|0 P:(DE-He78)fab123fab286a8dcfd7f622e70598d6a
|b 1
700 1 _ |a Berger, Emanuel
|b 2
700 1 _ |a Liu, Lei
|b 3
700 1 _ |a Gross, Nina
|b 4
700 1 _ |a Heinzmann, Florian
|b 5
700 1 _ |a Ringelhan, Marc
|b 6
700 1 _ |a Connor, Tracy O
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Stadler, Mira
|0 P:(DE-He78)475fbe15f759c77d8668a5031687c5a1
|b 8
700 1 _ |a Meister, Michael
|0 P:(DE-He78)aa3ff9fc2739d5cb7f822cbd7c1e39c9
|b 9
700 1 _ |a Weber, Julia
|b 10
700 1 _ |a Öllinger, Rupert
|b 11
700 1 _ |a Simonavicius, Nicole
|b 12
700 1 _ |a Reisinger, Florian
|b 13
700 1 _ |a Hartmann, Daniel
|b 14
700 1 _ |a Meyer, Rüdiger
|b 15
700 1 _ |a Reich, Maria
|b 16
700 1 _ |a Seehawer, Marco
|b 17
700 1 _ |a Leone, Valentina
|b 18
700 1 _ |a Höchst, Bastian
|b 19
700 1 _ |a Wohlleber, Dirk
|b 20
700 1 _ |a Jörs, Simone
|b 21
700 1 _ |a Prinz, Marco
|b 22
700 1 _ |a Spalding, Duncan
|b 23
700 1 _ |a Protzer, Ulrike
|b 24
700 1 _ |a Luedde, Tom
|b 25
700 1 _ |a Terracciano, Luigi
|b 26
700 1 _ |a Matter, Matthias
|b 27
700 1 _ |a Longerich, Thomas
|b 28
700 1 _ |a Knolle, Percy
|b 29
700 1 _ |a Ried, Thomas
|b 30
700 1 _ |a Keitel, Verena
|b 31
700 1 _ |a Geisler, Fabian
|b 32
700 1 _ |a Unger, Kristian
|b 33
700 1 _ |a Cinnamon, Einat
|b 34
700 1 _ |a Pikarsky, Eli
|b 35
700 1 _ |a Hüser, Norbert
|b 36
700 1 _ |a Davis, Roger J
|b 37
700 1 _ |a Tschaharganeh, Darjus Felix
|0 P:(DE-He78)ceccc9aed8c6e89c00795bce1f1d83a3
|b 38
700 1 _ |a Rad, Roland
|b 39
700 1 _ |a Weber, Achim
|b 40
700 1 _ |a Zender, Lars
|0 P:(DE-He78)1ba2900406378e069d32db376c7818db
|b 41
700 1 _ |a Haller, Dirk
|b 42
700 1 _ |a Heikenwälder, Mathias
|0 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5
|b 43
|e Last author
773 _ _ |a 10.1016/j.ccell.2017.05.006
|g Vol. 31, no. 6, p. 771 - 789.e6
|0 PERI:(DE-600)2074034-7
|n 6
|p 771 - 789.e6
|t Cancer cell
|v 31
|y 2017
|x 1535-6108
909 C O |p VDB
|o oai:inrepo02.dkfz.de:124440
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)b7267d2eb18316483adbd62e60d9a3ad
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)fab123fab286a8dcfd7f622e70598d6a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)475fbe15f759c77d8668a5031687c5a1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)aa3ff9fc2739d5cb7f822cbd7c1e39c9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 38
|6 P:(DE-He78)ceccc9aed8c6e89c00795bce1f1d83a3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 41
|6 P:(DE-He78)1ba2900406378e069d32db376c7818db
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 43
|6 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-316
|2 G:(DE-HGF)POF3-300
|v Infections and cancer
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2017
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER CELL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b CANCER CELL : 2015
920 1 _ |0 I:(DE-He78)F180-20160331
|k F180
|l Chronische Entzündung und Krebs
|x 0
920 1 _ |0 I:(DE-He78)V076-20160331
|k V076
|l Translationale Gastrointestinale Onkologie
|x 1
920 1 _ |0 I:(DE-He78)F190-20160331
|k F190
|l Cell Plasticity and Epigenetic Remodeling
|x 2
920 1 _ |0 I:(DE-He78)L801-20160331
|k L801
|l DKTK Tübingen
|x 3
920 1 _ |0 I:(DE-He78)L701-20160331
|k L701
|l DKTK München
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F180-20160331
980 _ _ |a I:(DE-He78)V076-20160331
980 _ _ |a I:(DE-He78)F190-20160331
980 _ _ |a I:(DE-He78)L801-20160331
980 _ _ |a I:(DE-He78)L701-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21